ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,288Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 2061

$1.63M Total Retail Price of All Prescriptions

Rank: 27 out of 2061

893 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 893 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 893 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 21,840 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SYNTHROID 1,315 1,126 1 58
SIMVASTATIN 1,152 1,000 2 1
FUROSEMIDE 692 614 3 6
METOPROLOL TARTRATE 686 629 4 7
OMEPRAZOLE 627 522 5 5
POTASSIUM CHLORIDE 590 538 6 16
ATORVASTATIN CALCIUM 569 469 7 8
LISINOPRIL 509 458 8 2
AMLODIPINE BESYLATE 479 471 9 4
HYDROCODONE-ACETAMINOPHEN 384 358 S3 10 10
METFORMIN HCL ER 381 323 11 71
CRESTOR 356 337 12 31
LOSARTAN POTASSIUM 353 328 13 17
GABAPENTIN 344 313 14 15
PREDNISONE 342 282 15 32
CARVEDILOL 335 317 16 22
GLIMEPIRIDE 324 240 17 33
COUMADIN 296 247 18 218
HYDROCHLOROTHIAZIDE 291 287 19 12
CIPROFLOXACIN HCL 273 229 20 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 261 218 21 27
METFORMIN HCL 260 231 22 9
CLOPIDOGREL 257 223 23 29
FLUOXETINE HCL 257 191 23 73
CELEBREX 254 231 25 91
NEXIUM 240 191 26 26
ROPINIROLE HCL 227 183 27 92
TRAZODONE HCL 227 178 27 39
ZETIA 225 157 29 68
LOSARTAN-HYDROCHLOROTHIAZIDE 225 204 29 50
GLYBURIDE 212 181 R 31 60
ALPRAZOLAM 212 200 31 85
PLAVIX 204 167 33 49
AZITHROMYCIN 201 166 34 34
TRAMADOL HCL 197 135 35 18
PROAIR HFA 195 142 36 40
ATENOLOL 186 140 37 13
SERTRALINE HCL 186 156 37 21
ALLOPURINOL 177 164 39 28
ISOSORBIDE MONONITRATE ER 177 162 39 42
METOPROLOL SUCCINATE 174 152 41 19
LOVASTATIN 173 141 42 35
TRAMADOL HCL-ACETAMINOPHEN 171 153 43 194
PANTOPRAZOLE SODIUM 170 161 44 45
FLUTICASONE PROPIONATE 166 140 45 43
LANTUS 149 120 46 48
LANOXIN 145 143 47 391
ALENDRONATE SODIUM 141 117 48 25
DIOVAN 138 124 49 41
TAMSULOSIN HCL 135 131 50 30
PRAVASTATIN SODIUM 133 107 51 14
CLONIDINE HCL 121 111 52 52
LANTUS SOLOSTAR 116 89 53 76
DIOVAN HCT 115 115 54 99
TRICOR 111 84 55 128
DILTIAZEM 24HR ER 110 110 56 108
FENOFIBRATE 109 78 57 65
LIPITOR 108 74 58 70
ENALAPRIL MALEATE 108 107 58 75
ZOLPIDEM TARTRATE 107 90 60 23
ACEBUTOLOL HCL 106 106 61 386
LYRICA 106 90 61 83
DONEPEZIL HCL 102 95 63 24
EVISTA 98 86 64 150
SINGULAIR 98 72 64 88
LEVOTHYROXINE SODIUM 97 84 66 3
QUINAPRIL HCL 96 96 67 127
PAROXETINE HCL 94 91 68 61
ADVAIR DISKUS 94 84 68 57
OXYCODONE-ACETAMINOPHEN 90 71 S2 70 36
INSULIN SYRINGE 89 68 71 105
VENLAFAXINE HCL ER 89 72 71 109
NAMENDA 88 88 73 37
GEMFIBROZIL 86 85 74 107
VENTOLIN HFA 85 68 75 234
CITALOPRAM HBR 82 56 76 20
DICYCLOMINE HCL 77 74 77 207
ESTRADIOL 77 76 R 77 266
NIFEDICAL XL 73 73 79 259
ENABLEX 72 72 80 256
ACTOS 71 62 81 140
JANUVIA 71 58 81 51
CYMBALTA 70 54 83 59
CLONAZEPAM 69 67 84 241
KLOR-CON M20 69 69 84 47
NAPROXEN 69 64 84 110
OXYBUTYNIN CHLORIDE ER 66 65 87 80
DOXAZOSIN MESYLATE 65 57 88 81
BYSTOLIC 64 64 89 130
CILOSTAZOL 63 63 90 189
NIFEDIPINE ER 63 63 90 134
SPIRIVA 63 57 90 63
BUMETANIDE 61 48 93 136
MECLIZINE HCL 61 61 93 142
DEXILANT 60 29 95 236
PRISTIQ ER 59 53 96 376
TOPROL XL 58 58 97 169
VESICARE 58 48 97 269
NYSTATIN-TRIAMCINOLONE 58 35 97 224
WARFARIN SODIUM 58 53 97 11
AMITRIPTYLINE HCL 57 57 R 101 89
MELOXICAM 57 37 101 44
SYMBICORT 56 48 103 158
AMILORIDE-HYDROCHLOROTHIAZIDE 55 49 104 317
GLYBURIDE MICRONIZED 55 48 R 104 307
LANSOPRAZOLE 55 48 104 139
MONTELUKAST SODIUM 55 38 104 176
VERAPAMIL ER 54 54 108 100
MIRTAZAPINE 54 53 108 46
GLIPIZIDE ER 53 53 110 133
METOCLOPRAMIDE HCL 52 42 111 138
HYDRALAZINE HCL 51 51 112 69
DICLOFENAC SODIUM 51 32 112 147
GLYCOPYRROLATE 50 38 114 430
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.